`CVE-2026-103884`

Severity	6.5 Medium CVSS 3.1
Weakness	Path traversal (CWE-22)
Published	1 Oct 2026
Updated	6 Nov 2026

Published 44 days ago. NVD often adds the list of affected products days or weeks after a CVE is published, and the other sources we check lag too. The scope and status here may change.

Description

A flaw was found in the X.509 client certificate authenticator of Keycloak. When CRL Distribution Point checking is enabled, the server fails to properly validate the file paths provided in a client certificate. An attacker can provide a specially crafted certificate that causes the server to attempt to read sensitive files from the local system or exhaust memory by loading extremely large files, potentially leading to information disclosure or a system crash.

Exploitation status

No public exploit

No exploit has been reported in the sources we check.

CISA KEV not listed
VulnCheck KEV not listed
CISA Vulnrichment exploitation: none
Indexed PoC none indexed
EPSS 0.30% chance in 30 days

Waratek protection

Protected by Waratek

Waratek has a rule that blocks attacks on this vulnerability.

Protection full Path traversal
Action available security rule
Review automated Inferred
Record active

Decided by	A vulnerability class already blocked by an ARMR security rule
Finding	Protected by Waratek's ARMR path-traversal security rule, which blocks this class of attack at the JVM level without a rule written for this CVE specifically. The CVE's weakness is CWE-22: Path Traversal.
Candidate fix	https://access.redhat.com/security/cve/CVE-2026-103884 : a Red Hat CVE page: the weakest kind, naming no commit, though it shows Red Hat has looked at the CVE

Decided by

A vulnerability class already blocked by an ARMR security rule

Finding

Protected by Waratek's ARMR path-traversal security rule, which blocks this class of attack at the JVM level without a rule written for this CVE specifically. The CVE's weakness is CWE-22: Path Traversal.

Candidate fix

https://access.redhat.com/security/cve/CVE-2026-103884 : a Red Hat CVE page: the weakest kind, naming no commit, though it shows Red Hat has looked at the CVE

How to mitigate CVE-2026-103884

Apply the vendor's fix. Until you can, Waratek RASP blocks exploitation with its path traversal rule. It runs inside the Java application, with no code changes.

Waratek RASP Runtime protection for Java applications

References

URL	Tags
https://access.redhat.com/security/cve/CVE-2026-103884	redhat-cve
https://access.redhat.com/errata/RHSA-2026:95761
https://access.redhat.com/errata/RHSA-2026:95762

URL

Timeline

Published	2026-10-01	By the CVE Program.
NVD record modified	2026-11-06	NVD's own last-modified date for this record.

Published

2026-10-01

By the CVE Program.

NVD record modified

2026-11-06

NVD's own last-modified date for this record.

How VRT decided (20 of 24 rules ran)

20 of 24 rules ran. The rest didn't run because an earlier rule had already settled the CVE.

# Rule Outcome Status Detail

identity: Does this identifier describe a vulnerability at all? the first rule that matches decides

1 rejected no match CVE Program withdrawal of this identifier

scope: Is it a vulnerability Waratek protects? the first rule that matches decides

2 armr-patch-file no match An ARMR patch file on disk for this CVE

3 armr-secure-rule-file no match An ARMR security-rule template on disk for this CVE

4 manual-classification no match A researcher's recorded decision for this specific CVE

5 manual classification no match Manual classification of this CVE in the legacy dataset

6 non-java-upstream no match A root cause in non-Java code: an OS kernel, a C library, or a bundled runtime

7 oracle-component no match The defect being in a component of a tracked product the agent does not reach: JavaFX, the Java SE installer, the JInitiator browser plug-in, the native WebLogic proxy plug-in, or a native part of Oracle Application Server or Collaboration Suite (HTTP Server, Web Cache, Internet Directory, mail and calendar servers). Oracle gives these no CPE of their own and names them only in the description.

8 java-client-side no match Oracle's own risk-matrix note saying the CVE is reached only through untrusted code in the Java sandbox (applets, Web Start) or only through a client installation of Java, so a server running its own trusted code is not exposed

9 osv-maven no match An OSV.dev record of this CVE affecting a package published to Maven Central. When every such package is one business applications do not use (Minecraft mods and launchers, Fastjson) and no tracked product is named by CPE, it settles the CVE as Outside Waratek scope instead

10 cna-maven-package no match An affected Maven artifact named by the CNA itself

11 known-cpe-product no match An NVD CPE naming a product ARMR tracks

12 cna-cpe-product matched In scope cvelistV5 CPEs match known products: redhat/build_keycloak

13 oracle-advisory-family not reached A tracked product family named in Oracle's own risk matrix. CPE cannot carry a suite name, only a module.

14 cna-named-product not reached A tracked product named in words by the CVE's own CNA, on a record with no CPE yet. Apache and Eclipse publish these on advisory day, before NVD adds CPE data.

15 non-deployable-product not reached The only affected product being a sealed appliance image, where Java runs but no -javaagent can be attached

16 unmatched-product not reached No tracked product matched above, and none present at all

disposition: What do we do about one that is? every rule runs

17 patch-hint matched Mitigation candidate References include candidate fix URL (redhat-cve tier): https://access.redhat.com/security/cve/CVE-2026-103884

18 open-source-maven skipped The affected package being open source on Maven, so the fix can be read

19 poc-derivable skipped An indexed exploit clearing the evidence bar to reverse-engineer, where there is no source to read

20 no-exploit skipped Nothing to build a rule from yet: no published exploit, no CISA record of exploitation and no source-level change to read

21 secure-rule-match decided it matched Protected by Waratek CWE-22 (Path Traversal) is mitigable by an ARMR path-traversal security rule.

22 exploited-no-fix-or-poc skipped Somebody exploiting this CVE (a CISA or VulnCheck KEV listing, or a CISA verdict of active exploitation), with no fix, source code or PoC to build a rule from

23 below-action-threshold skipped Medium or Low severity, no CISA or VulnCheck KEV listing, no PoC clearing the evidence bar, no CISA verdict, no Oracle advisory

24 no-exploit-published skipped Exploit code for this candidate, published in a reviewed catalogue or a GitHub repository with 5 or more stars, or in use per CISA or VulnCheck; not only a CISA verdict, a forecast, or nothing at all

Products the scope rules checked

The products this CVE's record names, and whether VRT tracks each one. The scope rules decided on these.

Vendor Product Tracked CPE Source

redhat build_keycloak tracked cpe:/a:redhat:build_keycloak:26.6::el9 yaml

NVD ↗ · CVE.org ↗